Research programme: paclitaxel-coated balloon - SurModics

Drug Profile

Research programme: paclitaxel-coated balloon - SurModics

Alternative Names: Saveil drug-coated balloon - SurModics; SurVeil® DCB; SurVeil® drug-coated balloon

Latest Information Update: 09 Dec 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SurModics
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Immunosuppressants; Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Peripheral arterial disorders

Most Recent Events

  • 16 Aug 2017 SurModics plans the TRANSCEND clinical trial for Peripheral arterial disorders, in September 2017 (NCT03241459)
  • 06 Nov 2014 Preclinical trials in Peripheral arterial disorders in USA (Intra-arterial)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top